Opinion of the Transparency Council – Treatment with interferon-free therapy of patients with chronic hepatitis C
At its meeting on 10 February 2025, the Transparency Council adopted opinion No. 23/2025 on the appropriateness of introducing changes to the drug program B. 71. “Treatment with interferon-free therapy of patients with chronic hepatitis C (ICD-10: B18.2)”